Avastin panel tops make-or-break period for Roche - Reuters
Published by Google Inc. November 30th, 2007 in Google FDA News, Regulatory Affairs|
Avastin panel tops make-or-break period for Roche
Reuters - The US Food and Drug Administration has delayed approval of Avastin as a first-line treatment for metastatic breast cancer but its advisory panel will … Roche May Take Cholesterol Market After Pfizer Failed (Update2) |